JP2023516472A5 - - Google Patents

Info

Publication number
JP2023516472A5
JP2023516472A5 JP2022554408A JP2022554408A JP2023516472A5 JP 2023516472 A5 JP2023516472 A5 JP 2023516472A5 JP 2022554408 A JP2022554408 A JP 2022554408A JP 2022554408 A JP2022554408 A JP 2022554408A JP 2023516472 A5 JP2023516472 A5 JP 2023516472A5
Authority
JP
Japan
Application number
JP2022554408A
Other languages
Japanese (ja)
Other versions
JP7796660B2 (ja
JPWO2021180631A5 (https=
JP2023516472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/055748 external-priority patent/WO2021180631A1/en
Publication of JP2023516472A publication Critical patent/JP2023516472A/ja
Publication of JP2023516472A5 publication Critical patent/JP2023516472A5/ja
Publication of JPWO2021180631A5 publication Critical patent/JPWO2021180631A5/ja
Application granted granted Critical
Publication of JP7796660B2 publication Critical patent/JP7796660B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022554408A 2020-03-09 2021-03-08 重症急性呼吸器症候群コロナウイルス2(sars-cov-2)、インフルエンザa及びインフルエンザbを検出するための組成物及び方法 Active JP7796660B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202062987066P 2020-03-09 2020-03-09
US62/987,066 2020-03-09
US202063075579P 2020-09-08 2020-09-08
US63/075,579 2020-09-08
US202063122869P 2020-12-08 2020-12-08
US63/122,869 2020-12-08
PCT/EP2021/055748 WO2021180631A1 (en) 2020-03-09 2021-03-08 Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2), influenza a and influenza b

Publications (4)

Publication Number Publication Date
JP2023516472A JP2023516472A (ja) 2023-04-19
JP2023516472A5 true JP2023516472A5 (https=) 2024-02-26
JPWO2021180631A5 JPWO2021180631A5 (https=) 2024-02-26
JP7796660B2 JP7796660B2 (ja) 2026-01-09

Family

ID=74867541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554408A Active JP7796660B2 (ja) 2020-03-09 2021-03-08 重症急性呼吸器症候群コロナウイルス2(sars-cov-2)、インフルエンザa及びインフルエンザbを検出するための組成物及び方法

Country Status (7)

Country Link
US (2) US12195811B2 (https=)
EP (1) EP4118239A1 (https=)
JP (1) JP7796660B2 (https=)
KR (1) KR102938730B1 (https=)
CN (1) CN116171333A (https=)
CA (1) CA3166337A1 (https=)
WO (1) WO2021180631A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3166337A1 (en) * 2020-03-09 2021-09-16 F. Hoffmann-La Roche Ag Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2), influenza a and influenza b
CN115867805A (zh) * 2020-03-31 2023-03-28 乌普卡拉公司 用于快速检测生物样品中的目标分析物的装置和方法
CA3179579A1 (en) * 2020-04-06 2021-10-14 Octant, Inc. Pathogen diagnostic test
US20220042117A1 (en) * 2020-08-06 2022-02-10 Roche Molecular Systems, Inc. COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
CN113801963B (zh) * 2021-09-17 2024-03-26 佛山科学技术学院 一种检测冠状病毒的引物探针组合、试剂盒及方法
JP7825255B2 (ja) * 2021-09-22 2026-03-06 学校法人 名城大学 標的配列の検出方法及び標的配列の検出装置
CN114350849A (zh) * 2021-12-21 2022-04-15 圣湘生物科技股份有限公司 检测SARS-CoV-2的组合物、试剂盒、方法及其用途
CN114561495A (zh) * 2022-04-28 2022-05-31 广东国盛医学科技有限公司 核酸组合及其应用、病毒检测试剂盒和检测病毒的方法
CN114622042B (zh) * 2022-05-17 2022-08-19 北京肝病研究所 检测新型冠状病毒联合呼吸道病毒的引物探针组和检测试剂盒
CN121406831A (zh) * 2025-12-26 2026-01-27 圣湘生物科技股份有限公司 鉴别呼吸道病原体的核酸组合产品、pcr预混物、试剂盒及方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135587B2 (en) 1983-02-22 2002-12-18 Syngene, Inc. Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4996143A (en) 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5683896A (en) 1989-06-01 1997-11-04 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
EP1067134B1 (en) 1991-11-07 2004-07-28 Nanotronics, Inc. Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
JP4281877B2 (ja) 1996-06-04 2009-06-17 ユニバーシティ オブ ユタ リサーチ ファウンデーション 生物学的プロセスを実行し且つモニタリングするためのシステムと方法
EP1033411B1 (en) 1996-06-04 2006-02-22 University of Utah Research Foundation Fluorescent donor-acceptor pair
ATE280177T1 (de) 1997-03-20 2004-11-15 Hoffmann La Roche Modifizierte primer
US7339051B2 (en) 2003-04-28 2008-03-04 Isis Pharmaceuticals, Inc. Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
US20070042350A1 (en) 2003-07-14 2007-02-22 Ze Li Methods and compositions for detecting sars virus and other infectious agents
EP2361974A1 (fr) 2003-12-02 2011-08-31 Institut Pasteur Utilisation des proteines et des peptides codés par le genome d'une nouvelle souche de coronavirus associé au SRAS
WO2007039301A2 (en) 2005-10-05 2007-04-12 Roche Diagnostics Gmbh Non-fluorescent energy transfer
CA3166337A1 (en) * 2020-03-09 2021-09-16 F. Hoffmann-La Roche Ag Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2), influenza a and influenza b
US20210293815A1 (en) * 2020-03-17 2021-09-23 Detect, Inc. Self- administrable diagnostic test with integrated swab
US20220364157A1 (en) * 2020-03-27 2022-11-17 Pathogendx, Inc. Methods for Detecting Low Levels of Covid-19 Virus
US11308612B2 (en) * 2020-04-17 2022-04-19 Qure.Ai Technologies Private Limited Systems and methods for detection of infectious respiratory diseases
KR20230030639A (ko) * 2020-06-26 2023-03-06 세페이드 Sars-cov-2, 인플루엔자 및 rsv를 검출하는 방법
WO2022050141A1 (ja) * 2020-09-04 2022-03-10 東洋紡株式会社 マルチプレックスpcrによる呼吸器感染症の検査方法

Similar Documents

Publication Publication Date Title
BR112023012656A2 (https=)
JP2023516472A5 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)